Esperion Therapeutics | ESPR - Trade Creditors


Esperion Therapeutics reported $77.51M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Alnylam Pharmaceuticals USD 115.72M 1.87M Dec/2025
Alterity Therapeutics Limited AUD 1.27M 1.81M Dec/2024
Amarin USD 36.71M 8M Sep/2025
Amgen USD 20.89B 1.25B Dec/2025
Biogen USD 432M 18.9M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Cipla INR 30.35B 1.98B Sep/2025
CSL USD 3.17B 290M Dec/2025
Cytokinetics USD 105.62M 83.53M Dec/2025
Daiichi Sankyo JPY 568.5B 16.84B Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Esperion Therapeutics USD 77.51M 2.81M Sep/2025
Geron USD 11.26M 146K Dec/2025
Grifols EUR 1.04B 183.31M Jun/2025
Halozyme Therapeutics USD 20.9M 5.54M Dec/2025
Heron Therapeutics USD 12.02M 20K Sep/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
Merck USD 4.15B 102M Sep/2025
Minerva Neurosciences USD 945K 48K Sep/2025
Moderna USD 317M 50M Dec/2025
Nektar Therapeutics USD 15.56M 1.28M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
PTC Therapeutics USD 45.49M 8.87M Dec/2025
Puma Biotechnology USD 6.39M 962K Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Sanofi EUR 22.93B 927M Dec/2025
Sarepta Therapeutics USD 280.84M 186.83M Dec/2025
United Therapeutics USD 7.1M 460.9M Dec/2025
Vanda Pharmaceuticals USD 39.09M 33.28M Dec/2024